2021, Number 4
<< Back Next >>
Enf Infec Microbiol 2021; 41 (4)
Lymph node Kaposi’s sarcoma without skin lesions: unusual case presentation
Navarro SLM, González GMC, Hernández OAP, Estrada MBE
Language: Spanish
References: 16
Page: 173-176
PDF size: 195.03 Kb.
ABSTRACT
Kaposi’s sarcoma (KS) is a potentially malignant low-grade vascular lesion that occurs most frequently with
HHV-8-associated skin lesions, occasionally the tumor may arise in lymph nodes or at visceral area without obvious
dermal disease. Lymph node involvement is rare and occurs in less than 10% of cases, it only affects patients in
advanced stages disease, associated with a worse prognosis. It occurs in the endemic variant in young patients
with human immunodeficiency virus. Differential diagnoses include tuberculosis and Hodgkin’s lymphoma. Immune
restoration is the proposed treatment as well as chemotherapy plus antiretroviral therapy. We describe a
case report of a patient with human immunodeficiency virus infection with lymphadenopathy compatible with
Kaposi’s sarcoma without associated dermatological lesions.
REFERENCES
Turcu, M., Cotoi, O.S., Chira, L., Horváth, E. y Morariu, S,H., “Secondary involvement of lymph nodes in Kaposi sarcoma”, Rom J Morphol Embryol, 2011, 52 (3): 943- 946.
Grayson, W. y Pantanowitz, L., “Histological variants of cutaneous Kaposi sarcoma”, Diagn Pathol, 2008, 3 (1): 1-11. Salim Mohanna, B., Juvenal Sánchez, L., Ferrufino, J.C.,
Bravo, F. y Gotuzzo, E., “Sarcoma de Kaposi clásico ganglionar. Comunicación de tres casos”, Rev Médica Chile, 2007, 135: 1166-1170.
Vázquez-Aguirre, N.A., Arenas-Guzmán, R. y Juárez-Durán, E.R., “Sarcoma de Kaposi asociado con vih, Med Interna México, 2020, 36 (4): 570-574. Disponible en: https://doi.org/10.24245/mim.v36i4.3164. Cesarman, E., Damania, B., Krown, S.E., Martin, J.,
Bower, M. y Whitby, D., “Kaposi sarcoma”, Nat Rev Dis Prim, 2019, 5 (1).
Bishop, B.N. y Lynch, D.T., “Cancer, Kaposi Sarcoma”, StatPearls, StatPearls Publishing, 2018. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30521260.
Mohar, A., Volkow, P., Kaempffer-Ramírez, A.M., Sada, E., Soto, J.L., Pérez, F. et al., “sida y neoplasias en México”, Salud Publica Mex, 1995, 37 (6 se-): 533-538. Disponible en: https://saludpublica.mx/index.php/spm/ article/view/5881.
Centers for Disease Control and Prevention, “Guidelines for the prevention and treatment of opportunistic infections in hiv-infected adults”, 2015, 408.
Zoubeidi, H., Aydi, Z., Daoud, F., Rachdi, I., Koubaa, W., Jouini, R. et al., “Kaposi’s sarcoma presenting as lymphadenopathy in an immunocompetetn patient”, Eur J Case Reports Intern Med© efim, 2016, 3.
Ecklund, R.E. y Valaitis, J., “Kaposi’s sarcoma of lymph nodes. A case report”, Arch Pathol, 74: 224-229.
Ramos, C.V., Taylor, H.B., Hernández, B.A. y Tucker, E.F., “Primary Kaposi’s sarcoma of lymph nodes”, Am J Clin Pathol, 1976, 66 (6): 998-1003. Disponible en: https:// academic.oup.com/ajcp/article/66/6/998/1765290.
Bhana, D., Templeton, A.C., Master, S.P. y Kyalwazi, S.K., “Kaposi sarcoma of lymph nodes, Br J Cancer, 1970, 24 (3): 464-470.
Li, J., Wang, J., Yang, Y., Cai, P., Cao, J., Cai, X. et al., “Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with covid-19 in Wuhan, China: a retrospective analysis”, Antimicrob Resist Infect Control, 2020, 9 (1): 1-7.
Dossier, A., Meignin, V., Fieschi, C., Boutboul, D., Oksenhendler, E. y Galicier, L., “Human herpesvirus 8-related Castleman disease in the absence of hiv infection”, Clin Infect Dis, 2013, 56 (6): 833-842.
Mitsuyasu, R.T., “Clinical variants and staging of Kaposi’s sarcoma”, Semin Oncol, 1987, 14 (3): 13-28.
Paksoy, N., “Case report Revista da Sociedade Brasileira de Medicina Tropical simultaneous occurrence of Kaposi sarcoma and tuberculosis; Kaposi sarcoma and lymphoma in the same lymph node: a report on two hiv-positive patients from Zimbabwe”, J Brazilian Soc Trop Med, 52.
Full text